| abstract |
Disclosed is a pharmaceutical composition for safe cartilage regeneration, which has a feature that allows EP2 agonists to act on a diseased site for a long period of time and avoids side effects, and further avoids tissue irritation induced by a pharmaceutical base. To provide. A pharmaceutical composition comprising an EP2 agonist that may be contained in a hydrogel and a biodegradable polymer causes the EP2 agonist to act on a diseased site for a long period of time to avoid side effects. Therefore, it can be used as a pharmaceutical composition for cartilage regeneration that is highly durable and safe. [Selection figure] None |